David S Hong

Dr. David S Hong serves as Deputy Chair of the Department of Investigational Cancer Therapeutics within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center. His leadership role focuses on advancing experimental cancer therapies through clinical research and drug development initiatives.

His research spans investigational cancer therapeutics with emphasis on clinical trial design, novel drug combinations, and translational oncology. The department specializes in early-phase clinical trials for innovative cancer treatments, bridging laboratory discoveries to patient care through rigorous scientific methodology.

Dr. Hong actively contributes to MD Anderson's clinical trial ecosystem, which provides patients access to cutting-edge treatments unavailable elsewhere. His work supports the institution's mission to eliminate cancer through therapeutic innovation and personalized medicine approaches.